Provided by Tiger Trade Technology Pte. Ltd.

CervoMed

2.57
+0.09003.63%
Post-market: 2.630.0600+2.33%19:30 EDT
Volume:234.57K
Turnover:601.11K
Market Cap:38.86M
PE:-0.80
High:2.64
Open:2.54
Low:2.50
Close:2.48
52wk High:10.00
52wk Low:2.13
Shares:15.12M
Float Shares:9.60M
Volume Ratio:1.21
T/O Rate:2.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1959
EPS(LYR):-2.9824
ROE:-107.62%
ROA:-60.80%
PB:1.69
PE(LYR):-0.86

Loading ...

CervoMed Announces Private Placement to Advance Neurology Pipeline

TIPRANKS
·
Jun 10

CervoMed releases corporate presentation highlighting neflamapimod Phase 2b efficacy signal in dementia with Lewy bodies

Reuters
·
Jun 10

CervoMed announces $10.5M private placement

TIPRANKS
·
Jun 10

CervoMed prices unregistered $10.5 million private placement at $3.14 per unit

Reuters
·
Jun 10

CervoMed - Announces Private Placement With Anticipated Gross Proceeds of $10.5 Mln

THOMSON REUTERS
·
Jun 10

CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod Into Phase 3 for Dementia With Lewy Bodies

THOMSON REUTERS
·
Jun 10

Press Release: CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies

Dow Jones
·
Jun 10

CervoMed Shareholders Back Board, Pay and Incentive Plan

TIPRANKS
·
Jun 09

CervoMed shareholders approve Amendment No. 1 to 2025 equity incentive plan at annual meeting

Reuters
·
Jun 09

H.C. Wainwright Reaffirms Their Buy Rating on CervoMed (CRVO)

TIPRANKS
·
Jun 09

CervoMed Highlights Q1 Results and Neflamapimod Progress

TIPRANKS
·
May 19

CervoMed price target lowered to $9 from $11 at Roth Capital

TIPRANKS
·
May 19

CervoMed posts smaller-than-expected Q1 net loss

Reuters
·
May 18

CervoMed Inc - Plans to Initiate Phase 3 Trial Evaluating Neflamapimod in Patients With Dlb in the Second Half of 2026

THOMSON REUTERS
·
May 18

CervoMed Q1 Net Income USD -8 Million VS. Ibes Estimate USD -9.03 Million

THOMSON REUTERS
·
May 18

CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates

THOMSON REUTERS
·
May 18

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 18

Analysts Offer Insights on Healthcare Companies: Urogen Pharma (URGN) and CervoMed (CRVO)

TIPRANKS
·
May 18

CervoMed Q1 EPS $(0.86) Misses $(0.78) Estimate

Benzinga Earnings
·
May 16

Top News Today: Stocks Slide, Treasury Yields Rise on Strait, Inflation Fears

Dow Jones
·
May 16